Ensysce Biosciences Statistics Share Statistics Ensysce Biosciences has 2.37M
shares outstanding. The number of shares has increased by 212.9%
in one year.
Shares Outstanding 2.37M Shares Change (YoY) 212.9% Shares Change (QoQ) 68.72% Owned by Institutions (%) 0% Shares Floating 2.35M Failed to Deliver (FTD) Shares 391 FTD / Avg. Volume 0.09%
Short Selling Information The latest short interest is 159.41K, so 6.72% of the outstanding
shares have been sold short.
Short Interest 159.41K Short % of Shares Out 6.72% Short % of Float 6.8% Short Ratio (days to cover) 1.5
Valuation Ratios The PE ratio is -1.78 and the forward
PE ratio is -43.2.
Ensysce Biosciences's PEG ratio is
0.7.
PE Ratio -1.78 Forward PE -43.2 PS Ratio 2.73 Forward PS 0.1 PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0.7
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ensysce Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.42,
with a Debt / Equity ratio of 0.
Current Ratio 2.42 Quick Ratio 2.42 Debt / Equity 0 Debt / EBITDA -0.04 Debt / FCF n/a Interest Coverage -5.22
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $744.29K Profits Per Employee $-1.14M Employee Count 7 Asset Turnover 0.93 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -64.38% in the
last 52 weeks. The beta is 1.02, so Ensysce Biosciences's
price volatility has been higher than the market average.
Beta 1.02 52-Week Price Change -64.38% 50-Day Moving Average 2.19 200-Day Moving Average 4.75 Relative Strength Index (RSI) 50.43 Average Volume (20 Days) 456,388
Income Statement In the last 12 months, Ensysce Biosciences had revenue of 5.21M
and earned -7.99M
in profits. Earnings per share was -4.57.
Revenue 5.21M Gross Profit 5.21M Operating Income -6.73M Net Income -7.99M EBITDA -6.73M EBIT -6.73M Earnings Per Share (EPS) -4.57
Full Income Statement Balance Sheet The company has 3.5M in cash and 301.66K in
debt, giving a net cash position of 3.2M.
Cash & Cash Equivalents 3.5M Total Debt 301.66K Net Cash 3.2M Retained Earnings -129,544.3B Total Assets 4.61M Working Capital 2.64M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7,502.7B
and capital expenditures 0, giving a free cash flow of -7,502.7B.
Operating Cash Flow -7,502.7B Capital Expenditures n/a Free Cash Flow -7,502.7B FCF Per Share -4294619.35
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -129.17% and -153.3%.
Gross Margin 100% Operating Margin -129.17% Pretax Margin -153.3% Profit Margin -153.3% EBITDA Margin -129.17% EBIT Margin -129.17% FCF Margin -144005758.16%
Dividends & Yields ENSC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ENSC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 6, 2024. It was a
backward
split with a ratio of 1:15.
Last Split Date Dec 6, 2024 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -43.39 Piotroski F-Score 3
